Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes in Patients with Advanced Rheumatoid Arthritis: Analysis of the Final 10-Year Results of An Open-Label Extension of a Phase 3 Trial
Author(s):
Keystone, E.; Heijde, D. van der; Weinblatt, M.E.; Mozaffarian, N.; Guerette, B.; Kupper, H.; Liu, S.F.; Wolfe, B.; Kavanaugh, A.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S870-S871
